Advertisement

Annals of Surgical Oncology

, Volume 25, Issue 1, pp 137–147 | Cite as

Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy

  • Jay K. HarnessEmail author
  • Kalatu Davies
  • Christina Via
  • Elizabeth Brooks
  • April Zambelli-Weiner
  • Chirag Shah
  • Frank Vicini
Breast Oncology

Abstract

Background

Electron intraoperative radiotherapy (IORT) can be used during breast conserving surgery to treat early-stage invasive breast cancer. Using data from current clinical and observational studies, this study aimed to assess the impact of single-fraction electron IORT on local recurrence rates.

Methods

Studies on single-fraction electron IORT during breast conserving surgery were identified through a search of PubMed and Google Scholar, as well as through secondary referencing. Local recurrence rate was the main outcome of interest. A meta-analysis of proportions using a binomial distribution to model the within-study variability and a random effects model was conducted to estimate a pooled local recurrence rate. To estimate a 5-year recurrence rate, a single-sample Poisson-normal model was applied to model the probability of events occurring during a fixed period (60 months).

Results

The study identified 13 publications. The analysis demonstrated a pooled monthly local recurrence rate of 0.02% per person-month (95% confidence interval CI 0.00–0.06%) for the studies with a follow-up period shorter than 5 years, 0.03% per person-month (95% CI 0.02–0.06%) for studies with a follow-up period of 5 years or longer, and 0.02% per person-month (95% CI 0.01–0.04%) overall. Based on this model, the predicted 5-year local recurrence rate was 2.7% (range 1.9–3.7%).

Conclusions

According to the published literature, the rate of breast cancer local recurrence after electron IORT was 0.02% per person-month, with an adjusted 5-year recurrence rate of 2.7%. These findings support the recent guidelines from the American Society for Radiation Oncology (ASTRO) supporting the use of electron IORT for low-risk patients.

Notes

Acknowledgment

This study was funded by IntraOp Medical.

Disclosure

Decision Driver Analytics was a paid consultant to IntraOp Medical, and Jay K. Harness, MD, was a speaker for IntraOp Medical.

References

  1. 1.
    DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.CrossRefPubMedGoogle Scholar
  2. 2.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.CrossRefPubMedGoogle Scholar
  3. 3.
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Litiere S, Werutsky G, Fentiman IS, et al. Breast-conserving therapy versus mastectomy for stage I-II breast cancer: 20-year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.CrossRefPubMedGoogle Scholar
  6. 6.
    Agarwal S, Pappas L, Neumayaer L, Kokeny K, Agarwal J Effects of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149:267–74.CrossRefPubMedGoogle Scholar
  7. 7.
    Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.CrossRefPubMedGoogle Scholar
  8. 8.
    Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of earl breast cancer: 10-year follow-up results of two randomized controlled trials. Lancet Oncol. 2013;14:1086–94.CrossRefPubMedGoogle Scholar
  9. 9.
    Gage I, Recht A, Gelman R, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245–51.CrossRefPubMedGoogle Scholar
  10. 10.
    Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-beast radiotherapy for breast cancer: 5-year results of local control and overall survival from the TARGIT: a randomized trial. Lancet. 2014;383:603–13.CrossRefPubMedGoogle Scholar
  11. 11.
    Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomized controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.CrossRefPubMedGoogle Scholar
  12. 12.
    Manyam B, Tendulkar R, Cherian S, Vicini F, Badiyan SN, Shah C. Evaluating candidacy for hypofractionated radiation therapy, accelerated partial-breast irradiation, and endocrine therapy after breast-conserving surgery: a surveillance epidemiology and end results (SEER) analysis. Am J Clin Oncol. 2016. doi:  10.1097/COC.0000000000000332 PubMedGoogle Scholar
  13. 13.
    Vaidya JS, Bulsara M, Wenz F, et al. Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys. 2016;96:259–65.CrossRefPubMedGoogle Scholar
  14. 14.
    Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Affairs. 2008;27:759–96.CrossRefPubMedGoogle Scholar
  15. 15.
    Stijnen T, Hamza TH, Ozdemir P. Random-effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29:3046–67.CrossRefPubMedGoogle Scholar
  16. 16.
    Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141:259–77.CrossRefPubMedGoogle Scholar
  17. 17.
    Olthof ED, Versleijen MW, Huisman-de Wall G, et al. Taurolidine lock is superior to heparin lock in prevention of catheter related bloodstream infections and occlusions. PLoS ONE. 2014;9:e111216.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Cedolini C, Bertozzi S, Seriau L, et al. Feasibility of conservative breast surgery and intraoperative radiation therapy for early breast cancer: a single-center, open, non-randomized, prospective pilot study. Oncol Rep. 2014;31:1539–46.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Dall’Oglio S, Maluta S, Gabbani M, et al. Intraoperative electron radiotherapy in early-stage breast cancer: a mono-institutional experience. Poster #P4-16-08.Google Scholar
  20. 20.
    Frasson AL, Zerwes FP, Braga Filho AP, Barbosa FS, Koch HA. Intraoperative radiotherapy in the conventional linear accelerator room for early breast cancer treatment: an alternative choice in developing countries. J Exp Clin Cancer Res. 2007;26:379–84.PubMedGoogle Scholar
  21. 21.
    Hanna SA, de Barros AC, de Andrade FE, et al. Intraoperative radiation therapy in early breast cancer using linear accelerator outside of the operative suite: an “image-guided” approach. Int J Radiat Oncol Biol Phys. 2014;89:1015–23.CrossRefPubMedGoogle Scholar
  22. 22.
    Hershko D, Abdah-Bortnyak R, Nevelsky A, Gez E, Fried G, Kuten A. Breast-conserving surgery and intraoperative electron radiotherapy in early breast cancer: experience at the Rambam Health Care Campus. Isr Med Assoc J. 2012;14:550–4.PubMedGoogle Scholar
  23. 23.
    Kawamura M, Itoh Y, Sawaki M, et al. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome. Radiat Oncol. 2015;10:150.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lemanski C, Azria D, Gourgou-Bourgade S, et al. Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial. Radiat Oncol. 2013;8:191.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Mussari S, Sabino Della Sala W, Busana L, et al. Full-dose intraoperative radiotherapy with electrons in breast cancer: first report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol. 2006;182:589–95.CrossRefPubMedGoogle Scholar
  26. 26.
    Osti MF, Carnevale A, Bracci S, et al. Exclusive electron intraoperative radiotherapy in early-stage breast cancer: a monoinstitutional experience. Anticancer Res. 2013;33:1229–35.PubMedGoogle Scholar
  27. 27.
    Philippson C, Simon S, Vandekerkhove C, et al. Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the Jules Bordet Institute. Int J Breast Cancer. 2014;2014:627352.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Rocco N, Rispoli C, Iannone L, et al. Intraoperative radiation therapy with electrons in breast cancer conservative treatment: our experience. Int J Surg. 2014;12(Suppl 1):S75–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Wang X, Liu J, Wang W, Feng Q, Wang X. Clinical analysis of intraoperative radiotherapy during conserving surgery of early breast cancer in the Chinese Han population. Oncotarget. 2015;6:43120–6.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Leonardi MC, Maisonneuve P, Mastropasqua MG, et al. How do the ASTRO consensus guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys. 2012;83:806–13.CrossRefPubMedGoogle Scholar
  31. 31.
    Strnad V, Ott OJ, Hildebrandt G, et al. 5-Year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: a randomised phase 3, non-inferiority trial. Lancet. 2016;387:229–38.CrossRefPubMedGoogle Scholar
  32. 32.
    Livi L, Meattini I, Marrazzo L, et al. Accelerated partial-breast irradiation using intensity-modulated radiotherapy versus whole-breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–63.CrossRefPubMedGoogle Scholar
  33. 33.
    Shah C, Khwaja S, Badiyan S, et al Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Brachytherapy. 2013;12:278–84.CrossRefPubMedGoogle Scholar
  34. 34.
    Niel-Weise BS, Stijnen T, Van den Broek PJ. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review. J Hospital Infect. 2008;69:114–23.CrossRefGoogle Scholar
  35. 35.
    Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269–71.CrossRefPubMedGoogle Scholar
  36. 36.
    Stafford D, Szczys R, Becker R, Anderson J, Bushfield S. How breast cancer treatment decisions are made by women in North Dakota. Am J Surg. 1998;176:515–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Morrow M, White J, Moughan J, et al: Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254–62.CrossRefPubMedGoogle Scholar
  38. 38.
    Shah C, Tendulkar R, Smile T, et al. Adjuvant radiotherapy in early-stage breast cancer: evidence-based options. Ann Surg Oncol. 2016;23:3880–90.CrossRefPubMedGoogle Scholar
  39. 39.
    Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–7.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Shah C, Badiyan S, Khwaja S, et al. Evaluating radiotherapy options in breast cancer: dose intraoperative radiotherapy represents the most cost-efficacious option? Clin Breast Cancer. 2014;14:141–6.CrossRefPubMedGoogle Scholar
  41. 41.
    Liu FF, Shi W, Done SJ, et al. Identification of a low-risk luminal A breast cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol. 2015;33:2035–40.CrossRefPubMedGoogle Scholar
  42. 42.
    Correa C, Harris EE, Leonardi MC, et al. Accelerated partial-breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7:73–9.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2017

Authors and Affiliations

  • Jay K. Harness
    • 1
    Email author
  • Kalatu Davies
    • 2
  • Christina Via
    • 2
  • Elizabeth Brooks
    • 2
  • April Zambelli-Weiner
    • 2
  • Chirag Shah
    • 3
  • Frank Vicini
    • 4
  1. 1.Center for Cancer Prevention and TreatmentSt. Joseph HospitalOrangeUSA
  2. 2.Decision Driver Analytics/Translational Technologies International, LLCAshevilleUSA
  3. 3.Department of Radiation OncologyCleveland Clinic, Taussig Cancer InstituteClevelandUSA
  4. 4.Michigan Healthcare Professionals21st Century OncologyFarmington HillsUSA

Personalised recommendations